Dow Rallies 236 Points On Gains For Merck, UnitedHealth Stocks

Dow Jones01-21 22:45

DJ Dow Rallies 236 Points On Gains For Merck, UnitedHealth Stocks

This article was automatically generated by MarketWatch using technology from Automated Insights.

Buoyed by positive momentum for shares of Merck and UnitedHealth, the Dow Jones Industrial Average is climbing Wednesday morning.

Shares of Merck (Merck & Co. Inc.) and UnitedHealth (UnitedHealth Group Inc.) have contributed to the index's intraday rally, as the Dow (Dow Jones Industrial Average) was most recently trading 236 points higher (0.5%).

Merck's shares have gained $1.70 (1.6%) while those of UnitedHealth have climbed $4.82 (1.4%), combining for a roughly 40-point bump for the Dow.

Other components contributing significantly to the gain include Walt Disney (Walt Disney Co.), Nike (Nike Inc. Cl B), and Chevron (Chevron Corp.).

A $1 move in any of the index's 30 components results in a 6.16-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled January 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

January 21, 2026 09:45 ET (14:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment